| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 5 | |
| #2 | Argentina | 2 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | Israel | 2 | |
| #6 | Republic of Korea | 2 | |
| #7 | Singapore | 2 | |
| #8 | Taiwan | 2 | |
| #9 | WIPO (World Intellectual Property Organization) | 2 | |
| #10 | Brazil | 1 | |
| #11 | China | 1 | |
| #12 | EPO (European Patent Office) | 1 | |
| #13 | Mexico | 1 | |
| #14 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Tuna Mihriban | 16 |
| #2 | Faroudi Mustapha | 9 |
| #3 | Gaspar Miguel | 9 |
| #4 | Campbell Jamie | 9 |
| #5 | Kraman Matthew | 9 |
| #6 | Sandy Nikole | 9 |
| #7 | Kmiecik Katarzyna | 9 |
| #8 | Everett Katy Louise | 9 |
| #9 | Hebeis Barbara | 9 |
| #10 | Wollerton Van Horck Francisca | 9 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020229626A1 | Dosage regimes for the administration of a lag-3/pd-l1 bispecific antibody | |
| GB202000318D0 | Dosage regimes for the administration of LAG-3/PD-L1 bispecific antibody | |
| GB201914040D0 | Dosage regimes for the administration of lag-3/pd-l1 bispecific antibody | |
| GB201906807D0 | Dosages regimes for the administration of lag-3/pd-l1 bispectic antibody | |
| GB201811445D0 | Mesothelin and OX40 binding molecules | |
| GB201811450D0 | Mesothelin and CD137 binding molecules | |
| KR20190019144A | Binding molecules that bind to PD-L1 and LAG-3 |